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Abstract
Background: Obesity and metabolic syndrome are strongly associated with type 2 diabetes
mellitus and cardiovascular diseases, thus the increasing trend in their prevalence among children
and adolescents from developing countries requires a further understanding of their epidemiology
and determinants.
Methods and design: A cross-sectional study was designed to determine the prevalence of
metabolic syndrome among 6–10 year-old children from Bucaramanga, Colombia. A two-stage
random-cluster (neighborhoods, houses) sampling process was performed based on local city maps
and local statistics. The study involves a domiciliary survey; including a comprehensive socio-
demographic, nutritional and physical activity characterization of the children that participated in
the study, followed by a complete clinical examination; including blood pressure, anthropometry,
lipid profile determination, fasting glucose and insulin levels. The prevalence of metabolic syndrome
will be determined using definitions and specific percentile cut-off points for this population. Finally,
the association between components of metabolic syndrome and higher degrees of insulin
resistance will be analyzed through a multivariable logistic regression model. This study protocol
was designed in compliance with the Helsinki declaration and approved by the local ethics board.
Consent was obtained from the children and their parents/guardians.
Discussion:  A complete description of the environmental and non-environmental factors
underlying the burden of metabolic syndrome in children from a developing country like Colombia
will provide policy makers, health care providers and educators from similar settings with an
opportunity to guide primary and secondary preventive initiatives at both individual and community
levels. Moreover, this description may give an insight into the pathophysiological mechanisms
mediating the development of cardio-metabolic diseases early in life.
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Background
Cardiovascular diseases (CVD) are one of the major prob-
lems in public health and are responsible for more than
50% of all mortality in the western world [1]. CVD are not
exclusive to developed countries. Nowadays, men,
women and children from developing countries are recog-
nized as populations at risk of developing CVD due to the
nutritional, demographic, epidemiological and socioeco-
nomic transitions they have been facing during the past
few decades.
Persistent malnutrition, sedentary lifestyle and obesity
have been associated with alterations in the processes that
regulate the control of blood pressure and the action of
insulin on the metabolism of carbohydrates and lipids.
There is an urgent call to strategize health policies and
intervention programs to tackle the factors influencing
this phenomenon in the early stages of life [2]. Together
these factors are known as the metabolic syndrome (MS)
[3], a condition that is strongly associated with the devel-
opment of type 2 diabetes mellitus (DM) and CVD [4-7].
Metabolic Syndrome in children
Similar to adults, the prevalence of overweight and obese
children and adolescents has shown an increasing trend
[8-11]. Moreover, the association between obesity and the
clustering of CVD risk factors early in life, and their per-
sistence during adulthood has been explored by several
groups [12-19]. Data pertaining to MS in children are
scarce. This is in part due to the lack of a consensus on the
definition of MS in this population and to the inclusion
of children together with adolescents in most studies [20].
Furthermore, most of the epidemiological characteristics
of MS in children have been studied in developed coun-
tries and little is known about this condition and its asso-
ciation with insulin resistance (IR) in children from
developing countries. Several definitions for MS in chil-
dren have been postulated [21-24]; however, the cut-off
points for each of its components, as well as their diagnos-
tic and prognostic validity, remain unclear [20]. More
recent definitions of MS in children have tended to be age
and ethnic-specific and to take into account developmen-
tal changes during the growing process [25,26]. It is well
recognized that IR constitutes a crucial element linking
the presence of cardiovascular risk factors and the devel-
opment of CVD [27]. The Homeostasis Model Assessment
(HOMA) index is one of the surrogate methods used for
the evaluation of insulin sensitivity, and has proven to be
strongly associated with endothelial dysfunction and the
future development of DM and CVD [28].
Both, genetic and environmental factors interact and con-
tribute to the burden of MS; however, environmental fac-
tors seem to play a predominant role. The most
commonly described factors involved in the development
of MS include: rapid nutritional transition, rural-to-urban
migration, adoption of a sedentary lifestyle and maternal-
fetal related conditions [29]. There is now a general agree-
ment that all these elements need to be carefully analyzed
from local, culturally-sensitive and cost-effective perspec-
tives with the final goal of establishing globally acceptable
criteria for the early detection and intervention of MS.
Moreover, strategies for the management of MS require
the integration of multiple stakeholders such as govern-
ment and nongovernmental policy makers, interdiscipli-
nary health care providers and educational organizations.
The aim of this study is to determine the prevalence of MS
in 6–10 year-old children from Bucaramanga, Colombia,
based on sex and age adjusted percentile cut-off points for
the different anthropometric, hemodynamic and bio-
chemical parameters in this population. The secondary
objectives of this study involve a description of the chil-
dren's socio-demographic, nutritional and physical activ-
ity profile and the analysis of the association between the
proposed components of MS and higher degrees of IR
(using the HOMA index).
Methods and design
Design
Cross-sectional and population-based study.
Eligibility
Children, 6–10 years old, who had lived in Bucaramanga,
Colombia during the last 12 months were eligible. Those
with a history of menarche and/or Tanner stage ≥ 2, prior
diagnosis of DM or other endocrine disorder; and/or pre-
vious treatment with hormones or steroids (except for
sodium levothyroxine) during the last month were
excluded.
Sample size and method of recruitment
A sample size of 1282 children was calculated from the
total 6–10 year-old population from Bucaramanga (N =
40,793), Colombia. We based this calculation on an
expected prevalence of MS in children of 8%, an absolute
precision between 1–5%, a confidence level of 95% and a
design effect of 2. Using local city maps and local statistics
[30,31], a two-stage sampling process was performed (Fig-
ure 1). In the first stage, a random selection of neighbor-
hoods that had at least 50 children (clusters) was made. In
the second stage, a random selection of a maximum of 50
houses in each neighborhood was completed. All children
who fulfilled the inclusion criteria in each of the selected
houses were invited to participate in the study.
Data collection
During 16 months (July 2006–October 2007), a domicil-
iary survey for socio-demographic, nutritional and physi-
cal activity data collection was administered to theBMC Pediatrics 2009, 9:28 http://www.biomedcentral.com/1471-2431/9/28
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Study flow Figure 1
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children's caregivers by trained research assistants. On a
second visit, a complete physical examination (including
blood pressure and anthropometric measurements) and
blood withdrawal (for the determination of lipid profile,
fasting glucose and insulin levels), were performed by
trained physicians and nutritionists at the "Fundación
Cardiovascular de Colombia" (FCV).
Study variables
Demographic factors such as age, sex, ethnicity (visually
assessed by a trained research assistant), educational level,
and socioeconomic status were collected. Health care
availability was confirmed by checking children's health
insurance cards. Children's and family history were
obtained directly from their caregivers and whenever pos-
sible confirmed by legal documents (e.g. birth certificate
and medical records).
Smoking status was categorized as active and passive
exposure to cigarettes. Nutritional habits were collected
through a 24 hour recall. Physical activity was assessed by
asking the time (hours per day) the children spent doing
several activities such as sleeping, studying (both, at
school and home), doing moderate physical activity (e.g.
walking, biking, skating, playing in a pool, gymnastics,
ballet or dancing; playing at home or in a park; playing an
instrument), doing vigorous physical activities (running,
carrying heavy objects, biking and skating with considera-
ble speed, practicing competitive sports or dancing, play-
ing football, basketball or volleyball) and spending in
front of screens (e.g. television, computers or videog-
ames), during one day of the week and weekend. Physical
or neurological deficits were recorded if they were referred
by the caregivers.
Children's heart and respiratory rates were measured in a
comfortable condition after a 10-min resting period.
Blood pressure was measured three times (with 5 minutes
between each) with their arm supported at the level of the
heart and seated quietly, using a automated blood pres-
sure monitor (Dinamap Pro 100; GE Medical Systems
Information Technologies, Inc., Milwaukee, Wisconsin)
and following the recommendations of the National High
Blood Pressure Education Program (NHBPEP) Working
Group on Children and Adolescents [32]. Percentiles of
blood pressure according to the percentiles of weight/age
were determined [33,34].
Anthropometric variables (weight, height, skin-folds,
waist and hip circumferences) were measured in duplicate
by two independent nutritionists, in the morning after
urine elimination, with the child using light clothing and
no shoes [34,35]. The Body Mass Index (BMI) was calcu-
lated according to the CDC recommendations [36,37].
Percentiles of weight/age and of BMI were also deter-
mined [38].
Under fasting conditions (at least 10 hours), blood sam-
ples were taken from the antecubital vein. Glycemia and
Lipid Profile were immediately quantified by a routine
colorimetric method (Biosystems BTS-303 Photometric,
Spain). Part of the samples were stored at -80°C, and insu-
lin determinations assessed by electrochemiluminescence
immunoassay "ECLIA" technique (Roche Elecsys 1010/
2010 and MODULAR ANALYTICS E170 (Elecsys module)
immunoassay analyzers) in one assay at the end of the
study. The HOMA Index was obtained from a mathemat-
ical model using the following formula: (22.5/[IF*GF]) -
(IF: Fasting insulin levels in IU/L, GF: Fasting glucose levels
in mmol/L) [39].
Data quality and statistical analyses
Study forms were reviewed to ensure they were complete
before data entry. Data were entered by duplicate into
Microsoft Excel spreadsheets (Microsoft Corp., Redmond,
Wash.) and compared using Epi-Info 2000. Any discrep-
ancy was corrected using the original study forms. The
phase of data analysis is now in progress. Bivariable anal-
yses for dichotomous and continuous variables will be
performed by chi-square test, t-tests or Mann-Whitney
tests, respectively. The association between components
of MS and the higher quintile of the HOMA index will be
analyzed through a logistic regression model considering
adjustments by clustering effect. All p-values will be two-
tailed, with p < 0.01 considered statistically significant.
Data will be analyzed using Stata Statistical Software®:
Release 10.0. (College Station, TX: Stata Corporation).
Nutritional data will be analyzed using the software Ceres
version 1.02 "FAO 1998" (adapted version for Latin
America and the Caribbean).
Logistical considerations
During the recruitment phase we faced several security
issues. In order to assure that the sampling strategies were
not violated we asked for support from community lead-
ers and the local police department. We organized several
promotion and health campaigns in tolerance zones in
order to explain the purposes of the study, introduce the
study personnel to the community and to agree on areas
in which the survey and clinical examinations could be
performed.
Ethical considerations
The study protocol was designed in compliance with the
Helsinki declaration and approved by the Research Ethics
Board from the FCV. Consent was obtained from all par-
ticipants and from their parents/guardians. Additionally,
all children gave their verbal assent.BMC Pediatrics 2009, 9:28 http://www.biomedcentral.com/1471-2431/9/28
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Discussion
Environmental and non-environmental factors underly-
ing MS in developing countries could be different to those
described in other populations. Population-based
research on this topic needs to take in to account the pecu-
liarities and limited resources in these settings in order to
preserve methodological rigor. Despite facing some secu-
rity and logistical problems, a rigorous sampling method,
data collection and management were completed during
the first phase of this study. To our knowledge, this project
constitutes the first population-based study of cardiovas-
cular risk factors in Colombian scholars.
We strongly believe that the results of this study will help
establish globally acceptable criteria for the early detec-
tion and intervention of MS in children. Moreover, they
will provide policy makers, health care providers and edu-
cators from a developing country like Colombia with an
opportunity to guide primary and secondary preventive
initiatives at individual and community levels.
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